ERBB2 and breast carcinoma: It is important to note that MDA-MB-231 is a highly aggressive, invasive and poorly differentiated triple-negative (ER, PR and HER2 negative) breast cancer cell line and one of the most commonly used cell lines in cancer research laboratories [22].